Cy5.5 NHS Ester (Non-Sulfonated): Atomic Evidence for Near-Infrared Biomolecule Labeling

Executive Summary: Cy5.5 NHS ester (non-sulfonated) is a near-infrared fluorescent dye that forms stable amide bonds with primary amines in biomolecules, enabling site-specific conjugation and deep-tissue imaging (APExBIO). Its excitation and emission maxima are 684 nm and 710 nm, respectively, which minimize background autofluorescence (Kang et al., 2025). The dye is highly soluble in DMSO (≥35.82 mg/mL) but requires organic co-solvents due to low aqueous solubility. It is supplied as a solid and remains stable for 24 months at -20°C in the dark. Cy5.5 NHS ester has demonstrated efficacy in labeling proteins, peptides, and plasmid DNA, supporting in vivo fluorescence imaging and tumor delineation in preclinical models (internal review).

Biological Rationale

Labeling biomolecules with near-infrared (NIR) fluorescent dyes enables visualization and quantification in complex biological systems. The NIR spectral region (650–900 nm) reduces tissue autofluorescence and light scattering (Kang et al., 2025). Cy5.5 NHS ester (non-sulfonated) is designed to label amino groups (–NH2) in peptides, proteins, and oligonucleotides. This specificity allows researchers to track biomolecule localization, study tumor microenvironments, and assess the pharmacokinetics of labeled agents in vivo.

Recent studies have shown that the tumor microenvironment contains distinct bacterial populations that influence metastasis and immune responses (Kang et al., 2025). NIR fluorescent dyes like Cy5.5 NHS ester are critical for visualizing tumor-associated processes and evaluating therapeutic interventions (internal analysis). This article extends prior work by providing atomic-level evidence and clarifying technical boundaries for Cy5.5 NHS ester (non-sulfonated) in translational oncology and molecular diagnostics.

Mechanism of Action of Cy5.5 NHS Ester (Non-Sulfonated)

Cy5.5 NHS ester (non-sulfonated) contains an N-hydroxysuccinimide (NHS) ester functional group. This group reacts specifically with primary amines (–NH2) on lysine residues or N-termini of peptides, proteins, and oligonucleotides. The reaction forms a stable amide bond, covalently linking the Cy5.5 fluorophore to the biomolecule (mechanistic review).

• The reaction is most efficient at pH 7.5–8.5 in buffered aqueous solutions containing organic co-solvent (e.g., DMSO, DMF).
• Cy5.5 NHS ester is highly soluble in DMSO (≥35.82 mg/mL) but poorly soluble in water; thus, it should be dissolved immediately prior to use in a dry organic solvent.
• After conjugation, unreacted dye is removed by size exclusion or dialysis.
• The labeled biomolecule displays excitation at 684 nm and emission at 710 nm, suitable for in vivo fluorescence detection.

This chemistry ensures site-specific, reproducible labeling with minimal structural or functional perturbation to the target biomolecule.

Evidence & Benchmarks

• Cy5.5 NHS ester (non-sulfonated) labels primary amines in peptides, proteins, and oligonucleotides with >95% efficiency under standard reaction conditions (pH 8.3, 30 min, DMSO co-solvent) (Kang et al., 2025).
• The dye exhibits an excitation maximum at 684 nm and an emission maximum at 710 nm, verified by spectrophotometry (APExBIO).
• In vivo imaging studies show clear tumor delineation and low background autofluorescence in live animal models following Cy5.5 NHS ester labeling (Kang et al., 2025).
• Stability data confirm that the solid dye is stable for 24 months at -20°C in the dark, but not stable in solution; immediate use after dissolution is required (APExBIO).
• Compared to sulfonated variants, the non-sulfonated Cy5.5 NHS ester offers higher membrane permeability but lower aqueous solubility, favoring in vivo and intracellular applications (internal review).

Applications, Limits & Misconceptions

Cy5.5 NHS ester (non-sulfonated) is used in several core applications:

• Fluorescent labeling of proteins and peptides: Enables tracking, quantification, and functional studies in molecular biology.
• Optical imaging of tumors: Provides real-time, high-contrast visualization of tumor boundaries during in vivo studies.
• Molecular imaging of microbiome–tumor interactions: Supports translational research into tumor-associated bacteria and their modulation (Kang et al., 2025).
• Bio-conjugation for nanovaccine development: Assists in the creation of fluorescently labeled vaccine constructs for tracking and efficacy assessment (internal analysis; this article details atomic-level constraints not covered in the linked review).
• Advanced neuromodulation research: As discussed in previous work, this dye supports in vivo fluorescence imaging in neuroscience; this article focuses on translational oncology and clarifies parameter boundaries.

Common Pitfalls or Misconceptions

• Not water soluble: Cy5.5 NHS ester (non-sulfonated) is poorly soluble in aqueous buffers and must be dissolved in DMSO or DMF before use.
• Unstable in solution: The dye hydrolyzes in water; solutions should be prepared immediately before conjugation.
• Selectivity: The NHS ester reacts only with primary amines, not with thiols, carboxyls, or secondary amines.
• Photostability: The dye is sensitive to light; all handling steps require protection from prolonged light exposure.
• Storage: Long-term storage should be as a dry solid at -20°C, not in solution.

Workflow Integration & Parameters

To integrate Cy5.5 NHS ester (non-sulfonated) labeling into a workflow:

1. Dissolve the dye in anhydrous DMSO or DMF to a concentration of 1–10 mg/mL immediately before use.
2. Prepare the biomolecule in a suitable buffer (e.g., 0.1 M sodium bicarbonate, pH 8.3).
3. Add the dye solution to the biomolecule at a molar ratio of 3–10:1 (dye:biomolecule).
4. Incubate at room temperature for 30–60 min, protected from light.
5. Quench unreacted NHS ester with Tris or ethanolamine and purify the conjugate by gel filtration or dialysis.
6. Verify labeling by absorbance (684 nm) and fluorescence (710 nm) spectroscopy.

For detailed protocol optimization and troubleshooting, refer to the manufacturer's documentation (APExBIO Cy5.5 NHS ester A8103).

Conclusion & Outlook

Cy5.5 NHS ester (non-sulfonated) is a rigorously characterized near-infrared fluorescent dye for labeling amino groups in biomolecules, supporting precision imaging and translational oncology research. Its validated chemistry, robust in vivo performance, and clear application boundaries make it a reference standard for molecular imaging in the NIR spectrum (Kang et al., 2025). For ongoing advances in tumor-microbiome studies and nanovaccine tracking, this reagent remains indispensable. For additional mechanistic details, see the atomic evidence review, which this article extends by integrating recent translational benchmarks and best-practice parameters.